305 related articles for article (PubMed ID: 26996669)
1. Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.
Garibaldi F; Falcone E; Trisciuoglio D; Colombo T; Lisek K; Walerych D; Del Sal G; Paci P; Bossi G; Piaggio G; Gurtner A
Oncogene; 2016 Jul; 35(29):3760-70. PubMed ID: 26996669
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity.
Gurtner A; Falcone E; Garibaldi F; Piaggio G
J Exp Clin Cancer Res; 2016 Mar; 35():45. PubMed ID: 26971015
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP
Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974
[TBL] [Abstract][Full Text] [Related]
4. Modulation of microRNA processing by p53.
Suzuki HI; Yamagata K; Sugimoto K; Iwamoto T; Kato S; Miyazono K
Nature; 2009 Jul; 460(7254):529-33. PubMed ID: 19626115
[TBL] [Abstract][Full Text] [Related]
5. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
[TBL] [Abstract][Full Text] [Related]
6. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs.
Fukuda T; Yamagata K; Fujiyama S; Matsumoto T; Koshida I; Yoshimura K; Mihara M; Naitou M; Endoh H; Nakamura T; Akimoto C; Yamamoto Y; Katagiri T; Foulds C; Takezawa S; Kitagawa H; Takeyama K; O'Malley BW; Kato S
Nat Cell Biol; 2007 May; 9(5):604-11. PubMed ID: 17435748
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex.
Kawai S; Amano A
J Cell Biol; 2012 Apr; 197(2):201-8. PubMed ID: 22492723
[TBL] [Abstract][Full Text] [Related]
8. Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome.
Zhang Y; Hu Y; Fang JY; Xu J
Oncotarget; 2016 Mar; 7(10):11056-66. PubMed ID: 26840456
[TBL] [Abstract][Full Text] [Related]
9. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
10. Post-transcriptional regulation of the tumor suppressor p53 by a novel miR-27a, with implications during hypoxia and tumorigenesis.
Maqbool R; Lone SN; Ul Hussain M
Biochem J; 2016 Oct; 473(20):3597-3610. PubMed ID: 27531966
[TBL] [Abstract][Full Text] [Related]
11. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.
Mori M; Triboulet R; Mohseni M; Schlegelmilch K; Shrestha K; Camargo FD; Gregory RI
Cell; 2014 Feb; 156(5):893-906. PubMed ID: 24581491
[TBL] [Abstract][Full Text] [Related]
12. DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.
Sun X; Tang SC; Xu C; Wang C; Qin S; Du N; Liu J; Zhang Y; Li X; Luo G; Zhou J; Xu F; Ren H
J Cell Mol Med; 2015 Jun; 19(6):1357-65. PubMed ID: 25702703
[TBL] [Abstract][Full Text] [Related]
13. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer.
Kiga K; Fukuda-Yuzawa Y; Tanabe M; Tsuji S; Sasakawa C; Fukao T
RNA Biol; 2014; 11(11):1347-54. PubMed ID: 25483038
[TBL] [Abstract][Full Text] [Related]
15. HP1BP3, a Chromatin Retention Factor for Co-transcriptional MicroRNA Processing.
Liu H; Liang C; Kollipara RK; Matsui M; Ke X; Jeong BC; Wang Z; Yoo KS; Yadav GP; Kinch LN; Grishin NV; Nam Y; Corey DR; Kittler R; Liu Q
Mol Cell; 2016 Aug; 63(3):420-32. PubMed ID: 27425409
[TBL] [Abstract][Full Text] [Related]
16. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
17. LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5.
Jacob J; Favicchio R; Karimian N; Mehrabi M; Harding V; Castellano L; Stebbing J; Giamas G
Cancer Lett; 2016 Mar; 372(1):137-46. PubMed ID: 26739063
[TBL] [Abstract][Full Text] [Related]
18. Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53.
Zhao Y; Zhang C; Yue X; Li X; Liu J; Yu H; Belyi VA; Yang Q; Feng Z; Hu W
Cell Death Differ; 2015 Nov; 22(11):1824-36. PubMed ID: 25857266
[TBL] [Abstract][Full Text] [Related]
19. A novel function for the DEAD-box RNA helicase DDX-23 in primary microRNA processing in Caenorhabditis elegans.
Chu YD; Chen HK; Huang T; Chan SP
Dev Biol; 2016 Jan; 409(2):459-72. PubMed ID: 26601717
[TBL] [Abstract][Full Text] [Related]
20. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
